摘要
Recanalization of occluded vessels and timely reperfusion are the primary therapies for acute ischemic stroke(AIS),with endovascular thrombectomy proven as the most effective therapy for large-vessel recanalization and improved outcomes of AIS patients.However,despite a high recanalization rate of 90% or even higher,the rate of 3-month functional independence is approximately 50%,while mortality remains around 15%[1].
基金
supported by the Beijing Natural Science Foundation(JQ22020)
Beijing Nova Program(Z201100006820143)
the National Natural Science Foundation of China(82001257,82201618,and 81971114).
